McKinsey Cancer Center

The potential for AI to change cancer drug discovery and development

Featured experts

Dr. Björn Albrecht
Senior PartnerParis
Heads the McKinsey Cancer Center, Leads our Life Sciences Practice in France and leads our work on cancer globally, working with biotech and pharmaceutical companies, health systems, payors and providers
Alex Devereson
PartnerLondon
Advises bio-pharmaceutical companies and investors on innovation and growth through holistic R&D transformations and at-scale deployment of digital and analytics across the value chain

Featured insights

A glass beaker filled hallway with binary number in a blue liquid. Two blue molecules float around the top of the beaker.
Report
Generative AI in the pharmaceutical industry: Moving from hype to reality
-
Seamless pattern made from repeating laptop computers.
McKinsey Direct
Early adoption of generative AI in commercial life sciences
-
Fulfilling the promise of advanced analytics in oncology
Article
Fulfilling the promise of advanced analytics in oncology
-
Futuristic laboratory equipment. Rear view of scientist during DNA research
Article
AI in biopharma research: A time to focus and scale
-
Conceptual illustration for biotechnology
Article
How AI can accelerate R&D for cell and gene therapies
-
A small HUD showing a diagram of a human body and data with a doctor working with it.
Article
How artificial intelligence can power clinical development
-